C4 Therapeutics (CCCC) EPS (Basic) (2019 - 2026)
C4 Therapeutics' (CCCC) quarterly EPS (Basic) came in at -$0.22 in Q1 2026, up 41.42% year-on-year from -$0.15 in Q1 2025, and up 11.39% quarter-over-quarter from -$0.25 in Q4 2025.
C4 Therapeutics (CCCC) EPS (Basic) (2019 - 2026) Analysis & Trends
C4 Therapeutics' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.22 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 41.42% year-over-year to -$0.22 in Q1 2026; TTM through Mar 2026 was -$0.84, a 42.34% increase from a year earlier, with the FY2025 full-year figure at -$1.27, up 16.57% from the prior year.
- EPS (Basic) rose to -$0.22 in Q1 2026 per CCCC's latest filing, from -$0.25 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.22 in Q1 2026 and bottomed at -$2.64 in Q2 2022.
- The 5-year median for EPS (Basic) is -$0.5 (2024), against an average of -$0.62.
- Across the five-year window, EPS (Basic) sank 411.85% in 2022 and soared 72.22% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.76 in 2022, then grew by 8.0% to -$0.7 in 2023, then climbed by 28.82% to -$0.5 in 2024, then jumped by 50.7% to -$0.25 in 2025, then climbed by 11.39% to -$0.22 in 2026.
- Per Business Quant, the three latest CCCC EPS (Basic) figures stand at -$0.22 (Q1 2026), -$0.25 (Q4 2025), and -$0.44 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.25 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -0.41 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.73 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.76 |
| Sep 30, 2022 | -0.65 |
| Jun 30, 2022 | -2.64 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.51 |
| Jun 30, 2021 | -0.51 |